Tag: Eylea

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Eylea

Eylea data gives Regeneron/Bayer a lift in ophthalmic diseases - - Pharmaphorum

Added to Collection on: 2022-09-09 08:20:39

Tags for this article:

Medicine
Clinical medicine
Health
Breakthrough therapy
Angiogenesis inhibitors
Aflibercept
Bayer AG
Sanofi
Macular edema
Regeneron Pharmaceuticals
Ranibizumab
Macular degeneration
Regeneron
Bayer
Eylea

Click the tags to see associated articles and topics

View Article Details
Coherus Agrees to Acquire a Biosimilar EYLEA Candidate from Klinge Biopharma

Added to Collection on: 2023-01-13 17:41:27

Tags for this article:

Life Sciences
Articles
Biotechnology
Aflibercept
Bayer AG
Breakthrough therapy
Sanofi
Biosimilar
Biopharmaceutical
Eylea
Coherus Biosciences Inc.

Click the tags to see associated articles and topics

View Article Details
European regulator endorses high-dose version of Bayer eye drug Eylea | Reuters

Added to Collection on: 2023-11-10 19:38:59

Tags for this article:

Angiogenesis inhibitors
Breakthrough therapy
Monoclonal antibodies
Aflibercept
Sanofi
Macular edema
Regeneron Pharmaceuticals
Macular degeneration
Faricimab
Pharmaceutical industry
Bayer
Rinucumab
Eylea

Click the tags to see associated articles and topics

View Article Details
EyePoint sees stock surge on AMD drug trial data | BioPharma Dive

Added to Collection on: 2023-12-04 16:48:07

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Breakthrough therapy
Sanofi
Regeneron Pharmaceuticals
Macular degeneration
Macula
EyePoint Pharmaceuticals
Regeneron
Eylea

Click the tags to see associated articles and topics

View Article Details
CORRECTED-UPDATE 2-Regeneron preliminary Q4 US sales of Eylea below expectations

Added to Collection on: 2024-01-08 19:17:45

Tags for this article:

Regeneron Pharmaceuticals
Sanofi
Aflibercept
Viatris
Biosimilar
Mylan
Pharmaceutical industry
Bayer
Wells Fargo
United States
Eylea

Click the tags to see associated articles and topics

View Article Details
Regeneron preliminary Q4 US sales of Eylea below expectations - AOL.com

Added to Collection on: 2024-01-08 15:00:27

Tags for this article:

Regeneron Pharmaceuticals
Sanofi
Aflibercept
Viatris
Mylan
Biosimilar
Pharmaceutical industry
Bayer
Wells Fargo
Eylea
United States

Click the tags to see associated articles and topics

View Article Details
Amgen Launches Pavblu™ as the First EYLEA® Biosimilar in the U.S. | JD Supra

Added to Collection on: 2024-11-15 19:59:33

Tags for this article:

Sanofi
Aflibercept
Biosimilar
Regeneron Pharmaceuticals
Injunction
Biocon
Amgen
United States patent law
Regeneron
Eylea

Click the tags to see associated articles and topics

View Article Details
European Medicines Agency CHMP adopts positive opinions for two aflibercept biosimilars

Added to Collection on: 2025-02-03 18:29:55

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Monoclonal antibodies
Biosimilar
Macular edema
Committee for Medicinal Products for Human Use
European Medicines Agency
Macular degeneration
CHMP
Ranibizumab
Eylea

Click the tags to see associated articles and topics

View Article Details
Regeneron Misses on Eylea, Dupixent Sales; Issues First-Ever Dividends - BioSpace

Added to Collection on: 2025-02-04 15:25:53

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Leonard Schleifer
Aflibercept
Pharmaceutical industry
Blockbuster
Macular edema
Tuesday Morning
Dupilumab
Eylea

Click the tags to see associated articles and topics

View Article Details
REGENERON PHARMACEUTICALS, INC. SEC 10-K Report - TradingView

Added to Collection on: 2025-02-05 16:20:34

Tags for this article:

Regeneron Pharmaceuticals
Sanofi
Biosimilar
Pharmaceuticals policy
Bayer
Aflibercept
Pharmaceutical industry
Healthcare in the United States
Eylea
United States

Click the tags to see associated articles and topics

View Article Details